Clarifying the cardiac proteasome paradox: Protein quality control

Circulation Research

Volumn 111, Issue 5, 2012, Pages 509-511

  Glembotski, Christopher C ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

cardiac myocyte; ischemia; proteasome; protein; quality control; reperfusion

Indexed keywords

PROTEASOME; UBIQUITIN;

CONGESTIVE CARDIOMYOPATHY; HEART; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW;

ANIMALS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 84865521747     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.275917     Document Type: Review

References (31)

1. Roth DM, Balch WE. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol. 2011;23:126-134.
2. Doroudgar S, Glembotski CC. The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol Med. 2011;17: 207-214.
3. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest. 2002;110:1389-1398. (Pubitemid 35396907)
4. Glembotski CC. The role of the unfolded protein response in the heart. J Mol Cell Cardiol. 2008;44:453-459. (Pubitemid 351374700)
5. Claessen JH, Kundrat L, Ploegh HL. Protein quality control in the ER: balancing the ubiquitin checkbook. Trends Cell Biol. 2012;22: 22-32.
6. Shutt TE, McBride HM. Staying cool in difficult times: Mitochondrial dynamics, quality control and the stress response. Biochim Biophys Acta. 2012 Jun 7 [Epub ahead of print].
7. Haynes CM, Ron D. The mitochondrial UPR-protecting organelle protein homeostasis. J Cell Sci. 2010;123(Pt 22):3849-3855.
8. Wang X, Robbins J. Heart failure and protein quality control. Circ Res. 2006;99:1315-1328. (Pubitemid 44949667)
9. Kriegenburg F, Ellgaard L, Hartmann-Petersen R. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation. FEBS J. 2012;279:532-542.
10. Young GW, Wang Y, Ping P. Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med. 2008;18:93-98. (Pubitemid 351626605)
11. Gomes AV, Young GW, Wang Y, Zong C, Eghbali M, Drews O, Lu H, Stefani E, Ping P. Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics. 2009;8:302-315.
12. Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, Qiao X, Bardag-Gorce F, Ping P. Mapping the murine cardiac 26S proteasome complexes. Circ Res. 2006;99: 362-371. (Pubitemid 44253692)
13. Wang X, Li J, Zheng H, Su H, Powell SR. Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol. 2011;301:H2207-H2219.
14. Mearini G, Schlossarek S, Willis MS, Carrier L. The ubiquitinproteasome system in cardiac dysfunction. Biochim Biophys Acta. 2008; 1782:749-763.
15. Portbury AL, Willis MS, Patterson C. Tearin' up my heart: proteolysis in the cardiac sarcomere. J Biol Chem. 2011;286:9929-9934.
16. Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, Yasuoka N, Tsukihara T. The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure. 2002;10:609-618. (Pubitemid 34518706)
17. Jager S, Groll M, Huber R, Wolf DH, Heinemeyer W. Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. J Mol Biol. 1999;291: 997-1013. (Pubitemid 29403626)
18. Schlossarek S, Carrier L. The ubiquitin-proteasome system in cardiomyopathies. Curr Opin Cardiol. 2011;26:190-195.
19. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001; 276:30057-30063.
20. Powell SR, Davies KJ, Divald A. Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J Mol Cell Cardiol. 2007;42:265-269. (Pubitemid 44970471)
21. Li J, Horak KM, Su H, Sanbe A, Robbins J, Wang X. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest. 2011;121: 3689-3700.
22. Campbell B, Adams J, Shin YK, Lefer AM. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J Mol Cell Cardiol. 1999;31:467-476. (Pubitemid 29089894)
23. Pye J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, Adams J, Elliott PJ, Pien C, Fischer TH, Baldwin AS Jr, Nichols TC. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol. 2003;284: H919-H926. (Pubitemid 36228240)
24. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman CH. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg. 2007;84:120-125. (Pubitemid 46921115)
25. Tian Z, Zheng H, Li J, Li Y, Su H, Wang X. Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ Res. 2012;111: 532-542.
26. Hedhli N, Depre C. Proteasome inhibitors and cardiac cell growth. Cardiovasc Res. 2010;85:321-329.
27. Stansfield WE, Tang RH, Moss NC, Baldwin AS, Willis MS, Selzman CH. Proteasome inhibition promotes regression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 2008;294:H645-H650. (Pubitemid 351253275)
28. Scruggs SB, Ping P, Zong C. Heterogeneous cardiac proteasomes: mandated by diverse substrates? Physiology (Bethesda). 2010;26: 106-114.
29. Frank D, Kuhn C, Katus HA, Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med (Berl). 2006;84:446-468. (Pubitemid 43801324)
30. Sanger JM, Sanger JW. The dynamic Z bands of striated muscle cells. Sci Signal. 2008;1:pe37.
31. Smith MH, Ploegh HL, Weissman JS. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science. 2011;334:1086-1090.